Renal involvement is the major cause of morbidity and mortality in lupus. Besides autoantibodies, intrinsic renal factors may contribute to the susceptibility to lupus nephritis. To determine how different mouse strains that develop spontaneous lupus fare in their susceptibility to immune mediated nephritis, mice from six lupus-prone strains and two non-lupus control strains (B6 and BALB/c) were challenged with rabbit anti-GBM sera. Among the strains tested, NZM2410 (or NZM) mice developed severe glomerulonephritis (GN), whereas BXSB and B6.lpr, NZB mice were relatively resistant to anti-GBM disease, as were the BALB/c controls. BWF1 and B6.Yaa mice exhibited intermediate degrees of GN that was comparable to the B6 controls. The severity of the renal disease in these strains did not appear to be related to the degree of the systemic immune response to the administered rabbit Ig. In addition, cytokine profiling demonstrated differential urinary excretion of several molecules in the NZM mice, compared with the controls. Together with our previous reports, our studies demonstrate that lupus-prone strains vary in their susceptibility to immune mediated nephritis, despite similar levels of circulating autoantibodies and comparable degrees of immune complex deposition in the kidneys.
INTRODUCTION
Nephritis is a leading cause of morbidity and mortality in both human and murine systemic lupus erythematosus (SLE [1] [2] [3] [4] [5] [6] ). To a certain extent this is likely to be due to the production of potentially nephrophilic autoantibodies, including anti-dsDNA and anti-glomerular autoantibodies. [7] [8] [9] On the other hand, it is also clear that antibody-independent mechanisms may also contribute to nephritis in SLE. It has long been observed that there is considerable discordance between anti-nuclear antibody (ANA) levels and severity of glomerulonephritis (GN) in SLE, as reviewed. 10, 11 Studies in mouse strains that develop spontaneous lupus have indicated that GN and ANA production can be mediated by independent loci, and that nephritis can occur without the presence of ANAs. 12, 13 It has become evident that signals from the innate immune system also has an important role in immune-mediated nephritis, as recently reviewed. 14 An elegant study that has illustrated the role of antibody-independent contributions to lupus nephritis is reported by Shlomchik et al. 12 in the MRL/lpr mouse model of lupus. MRL/lpr mice that have B-cells but cannot secrete immunoglobulin (Ig) exhibit substantial interstitial nephritis and vasculitis although less marked than that seen in the un-manipulated MRL/lpr controls. These studies indicate that antibody-independent mechanisms, including contributions from T-cells, myeloid cells and resident renal cells may also serve to potentiate lupus nephritis.
Hence, it becomes important to study the genetic and molecular determinants of renal disease in lupus, independent of the determinants that dictate ANA (and anti-glomerular) antibody formation. In this respect, the anti-glomerular basement membrane (GBM)-induced nephritis model is emerging as an informative experimental tool. [15] [16] [17] [18] [19] [20] This may relate to the fact that anti-GBMinduced nephritis and spontaneously arising lupus nephritis share similar downstream cellular and molecular events that lead to renal pathology and dysfunction despite differing in the nature of the initial antibody deposits. 14 This powerful tool has helped to identify certain strains such as 129/sv, BUB, DBA/1, C58 and NZW as being particularly susceptible to immune-mediated nephritis and others such as A/J, AKR, BALB/c, C3H, C57BL/6, DBA/2, DDY, FVB, MRL, NOD, P/J, SB, SJL and SWR as being less susceptible. [15] [16] [17] It is intriguing that some strains that possess genetic elements for the evolution of spontaneous lupus nephritis are also susceptible to anti-GBM nephritis (for example, NZW), while others are clearly not (for example, MRL). These observations raise an important question-to what extent are strains prone to spontaneous lupus also susceptible to anti-GBM induced nephritis? Can the NZB/NZW, NZM2410 and BXSB genomes and the lpr and Yaa lupus accelerating loci directly impact end-organ disease development, independent of their impacts on autoantibody generation?
In this report, we assess the degree of nephritis in anti-GBM challenged C57BL/6.lpr (B6.lpr), C57BL/6.Yaa (B6. Yaa), BXSB, NZB, (NZB X NZW) F1 (BWF1), NZM2410 (NZM) lupus-prone mice as well as two control strains-BALB/c mice that are not susceptible to anti-GBM disease, and C57BL/6 (B6) mice that develop low-grade anti-GBM GN.
RESULTS

Proteinuria and azotemia in anti-GBM challenged mice
In order to assess the sensitivity of different lupus-prone strains to anti-GBM nephritis, we challenged non-lupus prone B6 and BALB/c control strains and a variety of spontaneous lupus-prone strains, namely, B6.lpr, B6.Yaa, BWF1, BXSB, NZB and NZM, with anti-GBM sera, and examined them over 14 days for evidence of clinical renal damage, as detailed in Materials and Methods. On day 0, before the beginning of the experiment, all lupus-prone strains exhibited urinary protein excretion rate of o1.2 mg per 24 h, on par with the levels observed in the control B6 and BALB/c strains ( Figure 1a) . Following anti-GBM challenge, although the B6 mice (both male and female) developed low-grade proteinuria, BALB/c mice were highly resistant to anti-GBM sera-induced kidney damage, as had been noted previously. 15, 17 Among the lupus strains studied, BWF1 and NZM mice exhibited significant increase in urinary protein excretion over the 14-day study period, closely followed by the B6.lpr and B6.Yaa strains. Though these results were not significantly different from the B6 levels, the levels of proteinuria in these strains were significantly higher compared with the BALB/c controls. Surprisingly, BXSB mice that develop high degree of spontaneous nephritis by 6 months of age, and the NZB strain that develops moderate kidney disease by 9 months of age, 5, 6 did not develop any significant proteinuria after 14 days of anti-GBM challenge.
We also assessed the severity of renal function impairment by measuring blood-urea-nitrogen (BUN) levels in the different strains, before and after anti-GBM sera challenge (Figure 1b) . Male BXSB mice displayed significantly higher levels of BUN at day 0, compared with control B6 mice. None of the other strains displayed any basal impairment in renal function. On day 14, following anti-GBM challenge, most of the tested strains, including B6.Yaa, B6.lpr, BXSB and NZM2410 (4/11 mice) displayed a moderate increase in BUN levels over the 14-day challenge period. These levels were not statistically different from the levels in the B6 controls, though significantly higher than the levels in Figure 1 . Proteinuria and BUN in various strains after anti-GBM challenge. Mice from various strains (listed on X-axis) were challenged with anti-GBM sera. 24-h urine samples were collected on day 0 (D 0) and day 14 (D 14) , and protein excretion was measured (a). Blood samples were also collected on day 0 and day 14 for BUN measurements (b). Also depicted are the P value results upon comparing the data from the respective strains on D 14 against either B6 on D 14 (male or female, depending on the sex of the comparing strain) or BALB/c (female) on D 14 (N ¼ 4-11 for each strain). BALB/c mice do not display any gender-dependent differences in anti-GBM disease susceptibility (unpublished data).
the BALB/c controls. BWF1 and NZB mice did not display any increase in BUN following anti-GBM challenge.
Renal pathology in anti-GBM challenged mice After administration of anti-GBM serum, B6 mice developed varying degrees of proliferative GN, characterized by mesangial proliferation, matrix accumulation, focal necrosis, obliterated capillary lumens and crescent formation (Figures 2a and b) , consistent with our previous reports. 15 Mild to moderate tubulointerstitial nephritis could also be observed in these mice (Figure 2c ). Among the lupus-prone strains tested, NZM mice exhibited the most severe GN, with crescent formation and tubulointerstitial disease, compared with both the control strains, B6 and BALB/c, although there was significant mouse-to-mouse variation ( Figure 2 ). The BWF1 and B6.Yaa strains exhibited intermediate degrees of GN and tubulointerstitial disease that were comparable to the disease seen in the B6 controls, albeit being more severe than the pathology noted in the BALB/c controls ( Figure 2) . Interestingly, within the NZM strain, the four mice that developed the most severe proteinuria and the highest BUN values following anti-GBM challenge also displayed the highest degree of GN and crescent formation. The remaining strains, namely, B6.lpr, BXSB and NZB, displayed minimal renal disease, and were comparable to the BALB/c controls.
Systemic immune response to the administered anti-GBM sera in various strains To ascertain if the varied susceptibility to anti-GBM GN among these strains was due to differential xenogenic immune responses to the administered rabbit sera, we measured the levels of antirabbit IgG antibodies (Abs) in the sera 14 days after anti-GBM disease induction. As different Ig haplotypes may exhibit distinct affinities to the secondary detection Abs used for the assay, we compared the systemic immune responses among the strains sharing the same Ig haplotype. Among the three strains bearing the Ig haplotype b, B6 mice exhibited the lowest titers of IgG antibody to the administered rabbit Ig, while B6.lpr and B6.Yaa mice developed similar levels of IgG anti-rabbit Abs despite varying degrees of renal disease after challenge with anti-GBM sera ( Figure 3a ). Among the three strains bearing the Ig haplotype e (BWF1, NZB, NZM), NZB mice (that exhibited the least renal damage) exhibited the highest levels of Abs to rabbit Ig (data not shown). Thus, the degree of renal disease in the different strains did not correlate with the extent of the systemic xenogenic immune response.
To test if Th1 skewing contributes to the differing susceptibility to anti-GBM GN among the tested strains, we also measured IgG1 isotype and IgG2a isotype anti-rabbit Abs, which indirectly reflect the degree of Th2 and Th1 skewing, respectively. Interestingly, although IgG1 anti-rabbit Abs were comparable among the three strains with the B6 background and Ig allotype, the levels of IgG2a anti-rabbit Abs were significantly higher in B6.lpr mice (that developed minimal GN), compared with B6 mice (Figures 3b and  c) . The IgG2a:IgG1 ratios of anti-rabbit Abs were significantly lower in B6 mice, compared with B6.lpr and B6.Yaa mice (Figure 3d ). We did not note any differences in the levels of IgG1 or IgG2a isotype anti-rabbit Ig among the BWF1, NZB, NZW strains (data not shown). In addition, immunofluorescence analysis did not reveal any differences in rabbit IgG deposits in the glomeruli from different strains tested (Figure 3e ). Urinary cytokines profiling in anti-GBM challenged NZM and BALB/c mice In order to elucidate the potential mechanisms by which some lupus-prone strains may exhibit stronger susceptibility to anti-GBM GN, we screened the urine samples from one of the most susceptible strains, NZM, and the resistant strain, BALB/c, for 97 molecules using a planar cytokine array. Eleven of these molecules exhibited solid signal intensity (intensity unit of 100 or above) in at least one of the tested strains with at least 100% change from that of the control BALB/c mice (ratioX2.0 orp0.5). As shown in Figure 4a , the urine levels of decorin, E-selectin, L-selectin, Fmslike tyrosine kinase 3 (Flt-3 ) ligand, Galectin-1, hepatocyte growth factor activator inhibitor type 1 (HAI-1), interleukin-1, macrophage inflammatory protein-1g, soluble TNF receptor I, TNF-related weak inducer of apoptosis receptor were significantly higher in NZM mice, compared with BALB/c mice. In contrast, urine interleukin-4 level was significantly lower in NZM mice.
We then validated some of the array findings by ELISA (Figure 4b) . Interestingly, the serum decorin and Galectin-1 levels were constitutively higher in NZM mice before, during, and at the end of experiment, compared with the BALB/c controls. NZM mice excreted more decorin in the urine than BALB/c mice before the experiment, but the excretion was not significantly different between these two strains after disease induction. In contrast, NZM and BALB/c mice excreted similar amounts of Galectin-1 at baseline. After disease induction, however, NZM mice excreted more Galectin-1 than BALB/c mice, on day 8 (Po0.05), and day 14 (P ¼ 0.07). We did not capture any detectable levels of HAI-1 in the serum and urine samples from these two strains.
Inflammatory cell infiltration in anti-GBM challenged mice To investigate whether the difference in susceptibility to anti-GBM GN among the different strains might be mediated by renal inflammatory cells infiltration, kidney tissue from BABL/c. NWF1 and NZW2410 was stained for CD3 T cells and macrophages (n ¼ 4/each group). Of note, these three strains exhibited low, intermediate and high degrees of GN after anti-GBM challenge, respectively. It is not surprising that these three strains exhibited progressively increasing severity of inflammatory cell infiltration, as shown in Figure 5 . In anti-GBM challenged BALB/c mice, these were few infiltrating CD3 T cells and macrophages, while significantly increased T cell and macrophage infiltrates were seen in both the NZM2410 and NZWF1 mice, mainly around the tubulointerstitial areas.
DISCUSSION
Nephritis is a leading cause of mortality and morbidity in human SLE. [1] [2] [3] [4] Likewise, nephritis is the leading cause of mortality in murine lupus. 5, 6 Despite the clinical significance of this end-organ disease in lupus, it has never been clear if individuals or strains with lupus are intrinsically more susceptible to antibody-mediated nephritis. For instance, one can easily envisage a scenario whereby the aberrant renal intrinsic expression of various molecules (for example, cytokines, chemokines, complement, FcR, etc.) may render individuals more susceptible to nephritis, once ANAs and immune complexes get deposited within the kidneys. Likewise, although several nephritis associated loci have been mapped in human and murine lupus, whether these loci dictate intrinsic susceptibility to renal damage has never been ascertained.
In this context, the experimental anti-GBM-induced nephritis model constitutes a powerful tool for investigating the molecular basis of spontaneous lupus nephritis. Though experimental anti-GBM disease and spontaneous lupus nephritis differ in their inciting triggers, they share many downstream molecular pathways, as recently reviewed.
14 Hence, this presents us with the unique opportunity to evaluate how different lupus-prone strains vary in their susceptibility to antibody-mediated nephritis, using the experimental anti-GBM model. We have previously reported on how NZW and MRL mice fared in this model. 15, 16 The present study extends the observation to include six additional strains bearing lupus-associated genetic elements, B6.lpr, B6.Yaa, BWF1, BXSB, NZB and NZM2410. As captioned in Figure 6 , these strains vary significantly from each other in their susceptibility to anti-GBM disease.
The heightened anti-GBM disease noted in some strains (such as NZM) could reflect an enhanced xenogenic immune response to the administered rabbit anti-GBM sera, or renal intrinsic differences in the pathogenesis of nephritis, or both. Apparently, the enhanced susceptibility to anti-GBM GN in the NZM mice is not due to an exaggerated systemic immune response to the administered rabbit Ig, as NZM mice exhibited significantly lower levels of anti-rabbit Ig after anti-GBM challenge, compared with NZB mice that were resistant to anti-GBM GN. Likewise, although B6.lpr mice responded strongly to anti-GBM challenge, these mice developed minimal renal disease. We also failed to illustrate a possible role for Th1 skewing in contributing to the enhanced GN seen in the susceptible strains. Our current study and several other previous studies indicate that susceptibility to anti-GBM disease is not related to the quantity or quality of xenogenic immune response to the administered rabbit sera. [15] [16] [17] [18] [19] Among the different strains studied, the NZM2410 and NZW strains exhibited the most severe renal disease following anti-GBM challenge. This is perhaps not a surprise given the fact that 75% of the NZM2410 genome is NZW-derived. Indeed, several nephritisassociated loci of NZM2410/NZW-origin have been reported in the literature. These include Sle1 (88 cm on chromosome 1, LOD ¼ 10. Figure 6 . Differential susceptibility profiles of lupus-prone mouse strains to experimental anti-GBM induced GN. Plotted are severity of proteinuria (mean 24-h urinary excretion rate) and the mean GN scores from the eight lupus-prone strains examined either in the current study or in previous studies, 15, 16 14 days after induction of anti-GBM disease.
other un-named loci (reviewed in 21, 22 ). Among these, the first three have been individually bred onto the B6 background as congenic intervals. Out of these three congenics, Sle2 bearing mice are not susceptible to anti-GBM-induced disease (unpublished observations),whereas Sle3 bearing mice are significantly more susceptible to anti-GBM disease. 23 In addition, preliminary findings indicate that an additional sublocus within Sle1, termed Sle1d, 24 may also potentiate anti-GBM disease (unpublished observations). Hence, among the lupus-prone strains studied, the NZM2410 and NZW strains stand out as being highly susceptible to antibody-induced nephritis, possibly as a consequence of two genetic elements, Sle1d on chromosome 1 and Sle3 on chromosome 7.
A related lupus-prone strain is the BWF1 strain, derived as an F1 hybrid of NZB and NZW mice. Surprisingly, these mice exhibited only modest susceptibility to anti-GBM disease (Figures 1-3) , at levels comparable to the B6 controls. As NZW mice (that genotype as NZW/NZW at all loci) exhibit significantly more severe anti-GBM disease compared with BWF1 mice (that genotype as NZB/NZW at all loci), this difference may be attributed to recessive NZW alleles and or to NZB-derived suppressor loci. Indeed, both of these genetic elements may be contributing, given that NZB mice exhibit absolutely no evidence of anti-GBM disease (Figures 1-3) , and the fact that the nephritis susceptibility loci of NZW origin have previously been reported to be recessive or gene dose dependent in inheritance. 25 The BXSB and MRL.lpr strains are two additional strains that develop lupus nephritis spontaneously, by 6 months of age. 5, 6 Disease in the BXSB strain is partly driven by an accelerator locus, Yaa, 26, 27 recently uncovered to be TRL7. [28] [29] [30] Likewise, the disease in MRL.lpr mice is driven in part by the accelerator locus, lpr, which was previously shown to be a genetic ablation of FAS. 31 Although several loci associated with nephritis have been mapped in the BXSB (for example, Bxs1, Bxs2, Bxs4) and MRL.lpr strains (for example, FAS, Lrdm2, [32] [33] [34] ), our studies clearly illustrate that the BXSB, MRL and B6.lpr strains are not intrinsically susceptible to anti-GBM disease ( Figure 6 ). As the SB strain, one of the parental strains of BXSB, is resistant to anti-GBM disease, and the B6 strain, another parental strain of BXSB, is moderately sensitive to the disease, the BXSB strain may also harbor suppressor loci that impinge upon this phenotype. The Yaa locus is probably not suppressive of renal disease, as B6.Yaa mice exhibited moderate renal disease.
Although the highly susceptible mouse strain, NZM2410, exhibited elevated levels of decorin, E-selectin, L-selectin, Flt-3 ligand, galectin-1 and HAI-1, the pathogenic relevance of these molecules remains to be established. A molecule that is expressed locally may exert distinctly different effects compared with one that is circulating. For instance, as a member of small leucine-rich proteoglycans, decorin binds to matrix components, particularly collagen type I, to form fibrotic scars. However, it has also become clear that decorin possesses a potent anti-fibrotic effect, which may influence renal fibrogenesis directly through insulin like growth factor signaling and indirectly as a TGF-b neutralizing factor. [35] [36] [37] Galectins belong to a family of lectins that has an important role in apoptosis induction and immunomodulation. 38, 39 Indeed, it has been demonstrated that galectin-1 can ameliorate anti-GBM nephritis in rats. 40 Hence, it is tempting to speculate that the elevated decorin and galectin-1 may in part be related to the exaggerated renal disease in NZM mice, though this needs to be formally demonstrated.
In summary, the current study clearly demonstrates differing susceptibility of lupus-prone mouse strains to anti-GBM-induced GN. The differing susceptibility does not appear to be related to the quantity or quality of the systemic immune responses to the administered rabbit sera. The lupus-prone strains that are not susceptible to anti-GBM-induced renal disease may develop spontaneous lupus-associated renal damage following prolonged exposure to high levels of nephrophilic autoantibodies in a genetically programmed fashion. Bone marrow transfer and renal transplant studies are clearly warranted in order to confirm if renal intrinsic factors that are responsible for the heightened lupus nephritis seen in some of the strains which develop spontaneous disease. Extrapolating to the human disease, the present findings suggest that whereas some patients who develop lupus nephritis may possess genetically nephritis-prone kidneys, others may have perfectly sound end-organs.
MATERIALS AND METHODS
Rabbit anti-mouse GBM Sera GBM-reactive sera were generated as described previously. 15, 16 Essentially, mouse glomeruli were isolated by graded sieving, and the glomerular antigen harvested was sent to Lampire Laboratories (Pipersville, PA, USA) for generation of anti-GBM sera in rabbits. Sera obtained from these rabbits showed strong binding to the GBM, but not to the tubular basement membrane, as determined by immunofluorescence. This rabbit serum is referred to as 'anti-GBM serum'.
Mice and anti-GBM nephritis induction BALB/c, BXSB, C57BL/6 (or B6), C57BL/6.lpr (or B6.lpr), C57BL/6.Yaa (or B6.Yaa), NZB, NZM2410 (or NZM) and (NZB X NZW) F1 (referred to as BWF1) mice were purchased from the Jackson Laboratories (Bar Harbor, ME, USA) and subsequently bred and maintained in an specific pathogenfree colony. All studies have been reviewed and approved by the institutional review committee at UT Southwestern Medical Center in Dallas. Two to four month old female and male mice were used in these experiments. Anti-GBM nephritis was induced in mice presensitized with rabbit IgG in complete Freund's adjuvant (on day 0), by single intravenous injection of anti-GBM sera on day 5, as described previously. 15, 16 Twenty four hour urine samples were collected from all mice on day 0 and day14 using metabolic cages, with free access to drinking water. Urinary protein concentration was determined using the Coomassie Plus protein assay kit purchased from Pierce (Rockford, IL, USA). Blood was collected on day 0 and day 14 for measuring BUN, using urea nitrogen detecting reagents from Sigma (St. Louis, MO, USA). All animals were sacrificed on day14, and the kidneys were processed for light microscopy and immunofluorescence, as described below.
Histopathology
One kidney from each mouse was dissected into two parts. One part was fixed in 10% neutralized formalin for histological analysis, while the other was snap-frozen for immunofluorescence analysis. Three-micrometres sections of formalin-fixed, paraffin-embedded kidney tissues were sectioned, and stained with hematoxylin and eosin and Periodic Acid Schiff. These sections were examined for any evidence of pathology in the glomerular, tubulointerstitial and vascular compartments, as described previously. 15, 16 The severity of GN was graded on a scale of 0-4 based on the evidence of hypertrophy, proliferative changes, crescent formation, hyaline deposits, fibrosis/sclerosis and basement membrane thickening. The detail scale is: 0, normal; 1, mild increase in mesangial cellularity and matrix; 2, moderate increase in mesangial cellularity and matrix, with thickening of the GBM; 3, focal endocapillary hypercellularity with obliteration of capillary lumina and a substantial increase in the thickness and irregularity of the GBM; and 4, diffuse endocapillary hypercellularity, segmental necrosis, crescents and hyalinized end-stage glomeruli. Meanwhile, the percentage of glomeruli with evidence of crescent formation was also noted by counting at least 100 glomeruli per kidney. Tubular atrophy and dilatation, interstitial fibrosis are major tubulo-interstitial nephritis pathological damages, which was graded on a 0-4 scale as follows: 0, no lesions; 1, very mild focal dilation and/or very few foci of tubular atrophy; 2, larger number of dilated tubules with widening of interstitium and/or larger number of foci of tubular atrophy; 3, extensive dilation of tubules with cyst formation and widening of interstitium and/or a large number of foci of tubular atrophy; 4, atrophy of tubules. Rabbit IgG deposits in the kidneys were detected by direct immunofluorescence, using fluorescein isothiocyanate-coupled goat anti-rabbit Ig (Jackson Immunoresearch Laboratories, West Grove, PA, USA).
Immunohistochemistry staining
In order to address the underlying immunogenic mechanism in the different response to anti-GBM challenge among these strains, kidney tissue from three strains, BALB/c, BWF1 and NZM2410, are selected to detect the inflammatory cell infiltration. Kidney sections were cut at 4 mm and mounted onto poly-L-lysine coated glass slides. After dewax and rehydration, sections were treated with 3% hydrogen peroxide in methanol for 10 min to block endogenous peroxidase activity before antigen retrieval by standard microwave-based methods in citrate buffer. The sections were incubated with Abs to T cells (CD3, Cat. no. MCA1477, 1:400; AbD Serotec, Raleigh, NC, USA) and macrophages (F4/80, Cat. no MCA497GA,1:100; AbD Serotec, Raleigh, NC, USA). Immunohistochemistry was performed with using EXPOSE rabbit and mouse specific IHC kit (Abcam Inc, Cambridge, MA, USA). Finally, a light hematoxylin counterstain was applied to each section.
ELISA
Mouse Abs to rabbit Ig were assayed by ELISA, as described previously. 15, 16 Briefly, Immulon I plates (Dynatech, Chantilly, CA, USA), precoated with purified rabbit Ig (Sigma), were incubated with pretitrated mouse sera. Any unbound mouse anti-rabbit Ig was washed away. The bound Abs were detected using alkaline phosphatase conjugated goat-anti-mouse IgG (Roche, Indianapolis, IN, USA), followed by pNPP substrate (Sigma), at OD405. For the measurement of isotype-specific Abs, the secondary Abs were substituted with alkaline phosphatase-conjugated anti-mouse IgG1, or IgG2a (Zymed laboratories, San Francisco, CA, USA). Sera from the different mice were all assayed within the same microplate. Serum and urine levels of decorin, Galectin-1, and HAI-1 were measured using ELISA kits from the R & D System (Minneapolis, MN, USA), according to the manufacturer's manual.
Cytokine array analysis
The levels of 97 molecules in urine from anti-GBM-challenged NZM2410 and BALB/c mice on day 14 were detected simultaneously with RayBio Mouse Cytokine Antibody Array G series (Raybiotech, Norcross, GA, USA), according to the manufacturer's instruction. In brief, one hundred microliters of urine, pooled from five mice of each strain, was incubated on the array slide, followed by biotinylated detection antibody and fluorescence labeled streptavidin sequentially. The intensity of the signals was detected using a Genepix 4000B scanner, and then normalized based on prespotted positive controls on the arrays.
Statistics
For inter-group comparisons, the Student's t-test was used where normality tests were met. A non-parametric Mann-Whitney test was used where normality tests failed. For multi-group comparison, analysis of variance was used. Statistical analyses were performed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA, USA). All results are expressed as mean ± s.e.m.
